Blogs

Explore our latest pharmaceutical and healthcare blogs for expert perspectives, strategic insights, and emerging trends across R&D, market access, digital health, and regulatory science—curated to inform, inspire, and empower your next move.

December 4, 2025

The US-UK Drug Pricing Deal: What It Means for Both Countries and the Global Market

For years, the United States and the United Kingdom have…

December 2, 2025

Mergers & Acquisitions in Pharma — What 2025 taught us and where the momentum is heading in 2026

2025 almost felt like pharma pressed a reset button on…

November 26, 2025

Epilansis: A NextGen, Cloud-based Epidemiology Platform for Faster, Smarter Market Decisions

With the healthcare landscape shifting rapidly, teams across biopharma, consulting,…

November 14, 2025

Eight Emerging U.S. Medical Cost & Access Drivers to Watch in 2026

The U.S. healthcare system never really sits still but 2026…

November 14, 2025

The Forgotten Power of the TPP: Why Many Biopharma Projects Fail Without It

In the fast‐moving world of biopharma innovation, it’s easy to…

November 11, 2025

EU Pharmaceutical Supply Chain: How to Shrink Upstream Risk Without Shrinking Access

Europe’s pharmaceutical landscape is undergoing a significant change due to…

November 10, 2025

Pharma Licensing 2025 and Beyond: Rethinking Strategic Partnerships for Long-Term Value

Introduction: Licensing as a Growth Engine in Pharma The global…

November 10, 2025

FDA’s Updated Biosimilar Policy: What it really means in the US, EU5, Japan, and China

The regulatory landscape for biosimilars is shifting significantly in 2025.…

November 10, 2025

Pharma GCC Setup: A Strategic Feasibility Framework for Location and Talent Decisions

The pharma industry has seen a wave of change over…